Gastrointestinal Disorders

  • James W. Jefferson
  • John R. Marshall
Part of the Critical Issues in Psychiatry book series (CIPS)


The organ system which has received the most attention from psychiatrists is the gastrointestinal (GI) tract, and the importance of emotional factors in the genesis or treatment of diseases in this organ system is well accepted by clinicians of most specialities. Despite repeated clinical observations and extensive research from a psychosomatic viewpoint, a definitive understanding of the exact circumstances and mechanisms of many of the GI illnesses has not been clarified.


Irritable Bowel Syndrome Hepatic Encephalopathy Pancreatic Carcinoma Gastrointestinal Disorder Carcinoid Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams RD, Foley IM: The neurological disorder associated with liver disease, in Merritt HH, Hare CC (eds): Metabolic and Toxic Diseases of the Nervous System. Baltimore, Williams & Wilkins, 1953, vol 32, 198–237.Google Scholar
  2. Almy TP: What is the irritable colon? Am J Dig Dis 2: 93–97, 1957.PubMedCrossRefGoogle Scholar
  3. Alvarez WC: On Neuroses. Philadelphia, Saunders, 1951.Google Scholar
  4. Alvasaker JO, Brodwall E, Haarstad J: Nervous vomiting as the cause of electrolyte disturbances, kidney damage—and general tissue damage? Acta Med Scand 166: 331–336, 1960.CrossRefGoogle Scholar
  5. Alvin J, McHorse T, Hoyumpa A, et al: The effect of liver disease in man on the disposition of phenobarbital. J Pharmacol Exp Ther 192: 224–235, 1975.PubMedGoogle Scholar
  6. Ansari A: Carcinoma of the pancreas. Geriatrics 25: 91–99, 1970.PubMedGoogle Scholar
  7. Avery GS (ed): Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics. Sydney, Adis Press, 1976.Google Scholar
  8. Ayd FJ: Amitriptyline (Elavil) therapy for depressive reactions. Psychosomatics 1: 320–325, 1960.CrossRefGoogle Scholar
  9. Bacon PA, Myles AB: Hypoglycaemic coma after partial gastrectomy. Postgrad Med J 47: 134–136, 1971.PubMedCrossRefGoogle Scholar
  10. Baldessarini RJ, Fischer JE: Substitute and alternative neurotransmitters in neuropsychiatric illness. Arch Gen Psychiatry 34: 958–964, 1977.PubMedCrossRefGoogle Scholar
  11. Banjeri NK, Hurwitz LJ: Nervous system manifestations after gastric surgery. Acta Neurol Scand 47: 485–513, 1971.CrossRefGoogle Scholar
  12. Barnhart CC, Bowden CL: Toxic psychosis with cimetidine. Am J Psychiatry 136: 725–726, 1979.PubMedGoogle Scholar
  13. Barton MD, Libonati M, Cohen PJ: The use of haloperidol for treatment of post-operative nausea and vomiting—A double blind placebo-controlled trial. Anesthesiology 42: 508–512, 1975.PubMedCrossRefGoogle Scholar
  14. Bean WB, Funk D: Serotonin. Chicago, Yearbook Medical Publishers, 1968.Google Scholar
  15. Beaumont PJ, George JC, Smart DE: “Dieters” and “vomiters and purgers” in anorexia nervosa. Psycho] Med 6: 617–622, 1976.CrossRefGoogle Scholar
  16. Belding WL, Freedman DA: Postprandial hypoglycemia presenting as a neurologic problem. Neurology 10: 613–618, 1960.PubMedCrossRefGoogle Scholar
  17. Benjamin JE, Hoyt RC: Disability following postvaccinal (yellow fever) hepatitis. JAMA 128: 319–324, 1945.CrossRefGoogle Scholar
  18. Bonfils S, Dubrasquet M, Lambling A: Comparisons of two iminodibenzil derivatives on restraint-induced ulcers and gastric secretion. J Appl Physiol 17: 299–300, 1962.PubMedGoogle Scholar
  19. Brooks GM: Withdrawal from neuroleptic drugs. Am J Psychiatry 115: 931–932, 1959.PubMedGoogle Scholar
  20. Burkitt E, Sutcliff EC: Paralytic ileus after amitriptyline. Br Med J 2: 1648–1651, 1961.CrossRefGoogle Scholar
  21. Chen TS, Chen PS: Essential Hepatology. Massachusetts, Butterworth, 1977, pp 137–154.Google Scholar
  22. Cherry J: Pharyngeal location of symptoms of gastroesophageal reflux. Ann Otol Rhinol Laryngol 79: 912–915, 1970.PubMedGoogle Scholar
  23. Cleghorn RA, Brown WT: Psychogenesis of emesis. Can Psychiatr Assoc J 9: 299–310, 1964.Google Scholar
  24. Cohen CR: Emotional Factors in Gastrointestinal Illness. Lindner AE (ed). A Roche Medical Monograph Series. New York, American Elsevier Co, 1973, p 42.Google Scholar
  25. Cooke WT: Neurological manifestations of malabsorption, in Vinken J, Bruyn GW (eds): Clinical Handbook of Neurology 28:225–227, Amsterdam, North–Holland Publishing Co., 1976.Google Scholar
  26. Cooke WT: The neurologic manifestations of malabsorption. Postgrad Med J 54: 760–762, 1978.PubMedCrossRefGoogle Scholar
  27. Cooke WT, Smith WT: Neurologic disorders associated with adult coeliac disease. Brain 89: 683–722, 1966.PubMedCrossRefGoogle Scholar
  28. Coppens Al: Vomiting in early pregnancy. Lancet 1: 172–173, 1959.CrossRefGoogle Scholar
  29. Davidson CS, Gabuzda GJ: Hepatic coma, in Schiff L (ed): Diseases of the Liver. Philadelphia, Lippincott, 1975, pp 466–499.Google Scholar
  30. Delahunty JE, Ardran GM: Globus hystericus—a manifestation of reflux of oesophagitis. J Laryng 84: 1049–1064, 1970.PubMedGoogle Scholar
  31. Deutsch H: The Psychology of Woman. New York, Grune & Stratton, 1945.Google Scholar
  32. Diamond S: Amitriptyline in the treatment of gastrointestinal disorders. Psychosomatics 5: 221–224, 1964.PubMedGoogle Scholar
  33. Dickes R, Schinker V, Deutsch L: Serial liver-function and blood studies in patients receiving chlorpromazine. N Eng J Med 256: 1–7, 1957.CrossRefGoogle Scholar
  34. Dorfman W: Somatic components of depression. Psychosomatics 8: 4–5, 1967.PubMedGoogle Scholar
  35. Dujovne CA: A clinical pharmacologist’s view of drug hepatotoxicity. Pharmacol Res Commun 9: 1–15, 1977.PubMedCrossRefGoogle Scholar
  36. Ebert MH, Shader RI: Hepatic effects, in Shader RI, DiMascio A (eds): Psychotropic Drug Side Effects: Clinical and Theoretical Perspectives. Baltimore, Williams & Wilkins, 1970, pp 175–196.Google Scholar
  37. Elwood PC, Jacobs A, Pittman RG, et al: Epidemiology of Patterson-Kelly Syndrome. Lancet 2: 716–720, 1964.PubMedCrossRefGoogle Scholar
  38. Evans DL, Rogers JF, Peiper SC: Intestinal dilatation associated with phenothiazine therapy: A case report and literature review. Am J Psychiatry 136: 970–972, 1979.PubMedGoogle Scholar
  39. Fairweather DV: Nausea and vomiting in pregnancy. Am J Obstet Gynecol 102: 135–138, 1968.PubMedGoogle Scholar
  40. Fang MH, Ginsberg AL, Dobbins WO: Cholestatic jaundice associated with flurazepam hydrochloride. Ann Int Med 89: 363–364, 1978.PubMedGoogle Scholar
  41. Fann WE: Chlorpromazine: Effects of antacids on its gastrointestinal absorption. J Clin Pharmacol 13: 388–391, 1973.PubMedGoogle Scholar
  42. Feldman PE: The mask of depression. J Kans Med Soc 66: 6–10, 1965.PubMedGoogle Scholar
  43. Feurle GE, Bolk B, Waldherr R: Cerebral Whipple’s disease with negative jejunal histology. N Eng J Med 300: 907–908, 1979.CrossRefGoogle Scholar
  44. Finelli PF, McEntree WJ, Lussell S, et al: Whipple’s disease with predominantly neuroophthalmic manifestations. Ann Neurology 1: 247–252, 1977.CrossRefGoogle Scholar
  45. Forrest FM, Forrest IS, Serra MT: Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients. Biol Psychiatry 2: 53–59, 1970.PubMedGoogle Scholar
  46. Fras I, Litin EM: Comparison of psychiatric manifestations in carcinoma of the pancreas, retroperitoneal malignant lymphoma and lymphoma in other locations. Psychosomatics 8: 275–277, 1967.PubMedGoogle Scholar
  47. Fras I, Litin EM, Pearson JS: Comparison of psychiatric symptoms of carcinoma of the pancreas with those in some other intraabdominal neoplasms. Am J Psychiatry 123: 1553–1562, 1967.PubMedGoogle Scholar
  48. Gallant DM, Edwards CG, Bishop MP et al: Withdrawal symptoms after abrupt cessation of antipsychotic compounds: Clinical confirmation in chronic schizophrenics. Am J Psychiatry 121: 491–493, 1964.PubMedGoogle Scholar
  49. Gander DR, Devlin H: Ileus after amitriptyline. Br Med J 1: 1160–1161, 1963.PubMedCrossRefGoogle Scholar
  50. Goldberg D: A psychiatric study of patients with diseases of the small intestine. Gut 11: 459–465, 1970.PubMedCrossRefGoogle Scholar
  51. Granacher RP, Baldessarini RJ: The usefulness of physostigmine in neurology and psychiatry, in Klawans HL (ed): Clinical Neuropharmacology. New York, Raven Press, 1976, vol 1, pp 63–79.Google Scholar
  52. Greiner AC, Nicholson GA: Pigment deposition in viscera associated with prolonged chlorpromazine therapy. Can Med Assoc J 91: 627–635, 1964.PubMedGoogle Scholar
  53. Gullick HD: Carcinoma of the pancreas: A review and critical study of 100 cases. Medicine 38: 47–84, 1959.PubMedGoogle Scholar
  54. Hafken L, Leichter S, Reich T: Organic brain dysfunction as a possible consequence of postgastrectomy hypoglycemia. Am J Psychiatry 132: 1321–1324, 1975.PubMedGoogle Scholar
  55. Harris JG: Nausea, vomiting and cancer treatment. CA-A Cancer J Clinicians 28: 195–201, 1978.Google Scholar
  56. Havens LL, Child CG: Recurrent psychosis associated with liver disease and elevated blood ammonia. N Engl J Med 252: 756–759, 1955.PubMedCrossRefGoogle Scholar
  57. Heffernon EW, Lippincott RC: Gastrointestinal response to stress (irritable colon). Med Clin North Am 50: 591–595, 1966.PubMedGoogle Scholar
  58. Hill OW: Psychogenic vomiting and hypokalaemia. Gut 8: 98–101, 1967.PubMedCrossRefGoogle Scholar
  59. Hill OW: Psychogenic vomiting. Gut 9: 348–352, 1968.PubMedCrossRefGoogle Scholar
  60. Hislop IG: Psychological significance of the irritable colon syndrome. Gut 12: 452–457, 1971.PubMedCrossRefGoogle Scholar
  61. Hoyumpa AM, Branch RA, Schenker S: The disposition and effects of sedatives and analgesics in liver disease. Ann Rev Med 29: 205–218, 1978.CrossRefGoogle Scholar
  62. Jefferson JW: Central nervous system toxicity of cimetidine: A case of depression. Am J Psychiatry 136: 346, 1979.PubMedGoogle Scholar
  63. Kasich AM: Management of emotional disorders and depression in patients with gastrointestinal disease. J Ther Res 7: 542–547, 1965.Google Scholar
  64. Klotz U, Avant GR, Hoyumpa A, et al: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55: 347–359, 1975.PubMedCrossRefGoogle Scholar
  65. Knox DL, Bayless TM, Pittman FE: Neurologic disease in patients with treated Whipple disease. Medicine (Baltimore) 55: 467–476, 1976.Google Scholar
  66. Kohn LA: The behavior of patients with cancer of the pancreas. Cancer 5: 328–330, 1952.PubMedCrossRefGoogle Scholar
  67. Kornfeld DS: Psychiatric aspects of liver disease, in Lindner AE (ed): Emotional Factors in Gastrointestinal Illness. Amsterdam, Excerpta Medica, 1973, pp 166–181.Google Scholar
  68. Kraus JM, Desmond PV, Marshall JP, et al: Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther 24: 411–419, 1978.PubMedGoogle Scholar
  69. Kroger WS: Psychosomatic Obstetrics, Gynecology and Endocrinology. Springfield, Charles C Thomas, 1962.Google Scholar
  70. Kroll J, Fog R: Portal-systemic shunts and mental disorders. Acta Psychiatr Scand 44: 255–260, 1968.PubMedCrossRefGoogle Scholar
  71. Kronfeld A: Oesophagus-neurosen-psychotherapeut. Praxis 1: 21–27, 1934.Google Scholar
  72. Lacoursiere RB, Spohn HE, Thompson K: Medical effects of abrupt neuroleptic withdrawal. Compr Psychiatry 17: 285–294, 1976.PubMedCrossRefGoogle Scholar
  73. Latter KA, Wilbur DL: Psychic and neurologic manifestations of carcinoma of the pancreas. Staff Meetings Mayo Clin 12: 457–462, 1937.Google Scholar
  74. Lawton MP, Phillips RM: Psychopathological accompaniments of chronic relapsing pancreatitis. J Nery Ment Dis 122: 248–253, 1955.CrossRefGoogle Scholar
  75. Leevy CM: Exploring the brain—liver relationship. Mod Med 42: 17–22, 1974.Google Scholar
  76. Lehmann J: Mental disturbances followed by stupor in a patient with carcinoidosis. Acta Psychiatr Scand 42: 153–161, 1966.PubMedCrossRefGoogle Scholar
  77. Leibovich MA: Psychogenic vomiting. Psychother and Psychosom 22: 263–268, 1973.CrossRefGoogle Scholar
  78. Loiudice TA, Tulman A, Buhac I: L-Dopa and hepatic encephalopathy. NY State J Med 79: 364–366, 1979.Google Scholar
  79. Lowe WC, Palmer ED: Carcinoma of the pancreas. Am J Gastroenterol 47: 412–420, 1967.PubMedGoogle Scholar
  80. McMillen MA, Ambis D, Siegel JH: Cimetidine and mental confusion. N Eng J Med 298: 284–285, 1978.Google Scholar
  81. Major LE, Brown GL, Wilson WP: Carcinoid and psychiatric symptoms. South Med J 66: 787–790, 1973.PubMedCrossRefGoogle Scholar
  82. Maxwell JD, Carrella M, Parkes JD, et al: Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis. Clin Sci 43: 143–151, 1972.PubMedGoogle Scholar
  83. Milner G, Hills NF: Adynamic ileus and nortriptyline. Br Med J 1: 841–842, 1966.PubMedCrossRefGoogle Scholar
  84. Mitchell W, Feldman F: Neuropsychiatric aspects of hypokalaemia. Can Med Assoc J 98: 49–51, 1968.PubMedGoogle Scholar
  85. Morgan MH, Read AE: Antidepressants and liver disease. Gut 13: 697–701, 1972.PubMedCrossRefGoogle Scholar
  86. Morgan MY, Jakobovits A, Elithorn A, et al: Successful use of bromocriptine in the treatment of a patient with chronic portalsystemic encephalopathy. N Engl J Med 296: 793–794, 1977.PubMedCrossRefGoogle Scholar
  87. Morris JS, Ajdukiewicz AB, Reed AE: Neurologic disorders and adult coeliac disease. Gut 11: 549–554, 1970.PubMedCrossRefGoogle Scholar
  88. Mosley JW, Galambos JT: Viral hepatitis, in Schiff L (ed): Disease of the Liver, ed 3. Philadelphia, Lippincott, 1969, pp 410–497.Google Scholar
  89. Netter-Munkelt P, Mau G, Konig B: The dementia of neuroticism as a modifying factor in the association between biologic conditions and nausea in pregnancy. J Psychosom Res 16: 395–399, 1972.PubMedCrossRefGoogle Scholar
  90. Nicholls MG, Espiner EA: Surreptitious vomiting causing severe kypokalaemia: Case report. N Z Med J 77: 248–250, 1973.PubMedGoogle Scholar
  91. Olivarius B, Roos D: Myelopathy following partial gastrectomy. Acta Neurol Scand 44: 1347–1362, 1968.CrossRefGoogle Scholar
  92. Palmer RL: The psychosomatic study of vomiting of early pregnancies. J Psychosom Res 17: 303–308, 1973.PubMedCrossRefGoogle Scholar
  93. Parkes JD, Sharpstone P, Williams R: Levodopa in hepatic coma. Lancet 2: 1341–1343, 1970.PubMedCrossRefGoogle Scholar
  94. Paulley JW: Emotion and personality and etiology of steatorrhea. Am J Dig Dis 4: 352–360, 1959.PubMedCrossRefGoogle Scholar
  95. Peden NR, Cargill JM, Browning MCK, et al: Male sexual dysfunction during treatment with cimetidine. Br Med J 1: 659, 1979.PubMedCrossRefGoogle Scholar
  96. Perlas AP, Faillace LA: Psychiatric manifestations of carcinoma of the pancreas. Am J Psychiatry 121: 182, 1964.PubMedGoogle Scholar
  97. Plotkin DA, Plotkin D, Okun R: Haloperidol in the treatment of nausea and vomiting due to cytotoxic drug administration. Curr Ther Res Clin Exp 15: 599–601, 1973.PubMedGoogle Scholar
  98. Powell WJ, Koch-Weser J, Williams RA: Lethal hepatic necrosis after therapy with imipramine and desipramine. JAMA 206: 642–644, 1968.PubMedCrossRefGoogle Scholar
  99. Rash RM: Observations and the clinical features of carcinoma of the pancreas. Am J Gastroenterol 51: 235–245, 1969.PubMedGoogle Scholar
  100. Read AE, Sherlock S, Laidlaw J, et al: The neuro-psychiatric syndrome associated with chronic liver disease and an extensive portal-systemic collateral circulation. Quart JMed 36: 135–150, 1967.Google Scholar
  101. Reid AH, Leonard A: Lithium treatment of cyclical vomiting in a mentally defective patient. Br J Psychiatry 130: 316, 1977.PubMedCrossRefGoogle Scholar
  102. Rickles NK: Functional symptoms as first evidence of pancreatic disease. J Nery Ment Dis 101: 566–571, 1945.CrossRefGoogle Scholar
  103. Ritama V, Vapaatalohi, Neuvongn PJ, et al: Phenothiazines and intestinal dilatation. Lancet 1: 470–472, 1969.PubMedCrossRefGoogle Scholar
  104. Rivers A, Ferreira AE: Incidence and causes of chronic dyspepsia at various ages; an analysis of 4223 cases. JAMA 110: 2132–2136, 1938.CrossRefGoogle Scholar
  105. Robbins EL, Nagle JD: Haloperidol parenterally for treatment of vomiting and nausea from gastro-intestinal disorders in a group of geriatric patients: Double-blind placebo-controlled study. J Am Geriatr Soc 23: 38–41, 1975.PubMedGoogle Scholar
  106. Roberts R, Wilkinson GR, Branch RA, et al: Effect of age and cirrhosis on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterol 73: 1245 /1243, 1977.Google Scholar
  107. Rothermich NO, von Hamm E: Pancreatic encephalopathy. J Clin Endocrinol 1: 872–881, 1941.CrossRefGoogle Scholar
  108. Ruben J, Nagler R, Spiro HM, et al: Measuring the effects of emotions on esophageal motility. Psychosom Med 24: 170–175, 1962.Google Scholar
  109. Ruoff M: The irritable colon syndrome, in Lindner AE (ed): Emotional Factors in Gastrointestinal Illness. Amsterdam, Excerpta Medica, 1973, pp 156–164.Google Scholar
  110. Savage C, Butcher W, Noble D: Psychological manifestations in pancreatic disease. J Clin Exp Psychopathol 13: 9–12, 1972.Google Scholar
  111. Savage C, Noble D: Cancer of the pancreas: Two cases simulating psychogenic illness. J Nery Ment Dis 120: 62–65, 1954.CrossRefGoogle Scholar
  112. Schenker S, Breen KJ, Hoyumpa AM: Hepatic encephalopathy: Current status. Gastroenterol 66: 121–151, 1974.Google Scholar
  113. Schenker S, Hoyumpa AM, Wilkinson GR: The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics. Med Clin North Am 59: 887–896, 1975.PubMedGoogle Scholar
  114. Schentag JJ, Cerra FB, Calleri G, et al: Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1: 177–181, 1979.PubMedCrossRefGoogle Scholar
  115. Schuster MM, Iber FL: Psychosis with pancreatitis. Arch Intern Med 116: 118–233, 1965.CrossRefGoogle Scholar
  116. Sherlock S, Howligan K, George P: Medical complications of shunt surgery for portal hypertension. Ann NY Acad Sci 170: 392–405, 1970.CrossRefGoogle Scholar
  117. Sherlock S, Summerskill WHJ, White LP, et al: Portal-systemic encephalopathy, neurological complications of liver disease. Lancet 2: 453–457, 1954.CrossRefGoogle Scholar
  118. Shull HJ, Wilkinson GR, Johnson R, et al: Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 84: 420–425, 1976.PubMedGoogle Scholar
  119. Sokoloff B: Recent Results in Cancer Research: Carcinoid and Serotonin. New York, Springer—Verlag, 1966, vol 15.Google Scholar
  120. Summerskill WHJ, Davidson EA, Sherlock S, et al: The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Quart JMed 25: 245–266, 1956.Google Scholar
  121. Swanson DW, Swenson WN, Huizenga KA, et al: Persistent nausea without organic cause. Mayo Clinic Proc 51: 257–262, 1976.Google Scholar
  122. Thamsen L, Hjorth N, Christianson AR, et al: Cancer of the pancreas: A clinical and pathologic study. Acta Med Scand 139: 28–41, 1950.CrossRefGoogle Scholar
  123. Thorson A: Studies on carcinoid disease. Acta Med Scand 161 (suppl 334): 1–146, 1958.Google Scholar
  124. Tripp LE, Agle DP: Acute pancreatitis as a psychophysiologic response: A case study. Am J Psychiatry 124: 1253–1257, 1968.PubMedGoogle Scholar
  125. Tylden E: Hyperemesis and physiologic vomiting. J Psychosom Res 12: 85–89, 1968.CrossRefGoogle Scholar
  126. Uddenberg N, Nilsson A, Almgren PE: Nausea and pregnancy: Psychological and psychosomatic aspects. J Psychosom Res 15: 269–271, 1971.PubMedCrossRefGoogle Scholar
  127. Van Thiel DH, Gavaler JS, Smith WI, et al: Hypothalamic—pituitary—gonadal dysfunction in men using cimetidine. N Eng J Med 300: 1012–1015, 1979.CrossRefGoogle Scholar
  128. Victor M, Adams RD, Cole M: The acquired (nonWilsonian) type of chronic hepatocellular degeneration. Medicine 44: 345–396, 1965.PubMedCrossRefGoogle Scholar
  129. Vinson PO: Hysterical dysphagia. Minn Med 5: 107–112, 1922.Google Scholar
  130. Watson E: The role of auto-intoxication or auto-infection in mental disorders. J Ment Sci 69: 52–57, 1923.Google Scholar
  131. Weiss E, English OS: Cardiospasm, in Psychosomatic Medicine. Philadelphia, WB Saunders Co, 1957, pp 285–289.Google Scholar
  132. Wilbur DL, Washburn RN: Clinical features and treatment of functional or nervous vomiting. JAMA 110: 477–480, 1938.CrossRefGoogle Scholar
  133. Williams J, Hall GS, Thompson AG, et al: Neurologic disease after partial gastrectomy. Br Med J 3: 210–212, 1969.PubMedCrossRefGoogle Scholar
  134. Wolfe MM: Impotence on cimetidine treatment. N Eng J Med 300: 94, 1979.Google Scholar
  135. Wolff HP, Kruck F, Vecsei P, et al: Psychiatric disturbance leading to potassium depletion, sodium depletion, raised plasma-renin concentration, and secondary hyperaldosteronism. Lancet 10: 257–261, 1968.CrossRefGoogle Scholar
  136. Wooley OW: The Biochemical Basis of Psychosis. New York, John Wiley and Sons, 1962.Google Scholar
  137. Yaskin JC: Nervous symptoms as earliest manifestations of carcinoma of the pancreas. JAMA 96: 1664–1668, 1931.CrossRefGoogle Scholar
  138. Yon T, Anuras S: Hepatitis caused by amitriptyline therapy. JAMA 232: 833–834, 1975.PubMedCrossRefGoogle Scholar
  139. Young SJ, Elpers DH, Norland CC, et al: Psychiatric illness and the irritable bowel syndrome. Gastroenterol 70: 162–166, 1976.Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • James W. Jefferson
    • 1
  • John R. Marshall
    • 1
  1. 1.University of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations